Mutational Analysis of Residue 190 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase
S-2720 and other members of the quinoline/quinoxaline class of HIV-1-specific nonnucleoside reverse transcriptase inhibitors (NNRTIs) select for a glycine to glutamate substitution at residue 190 (Gly 190 Glu) of the reverse transcriptace (RT), when drug-resistant viruses are generated in cell cultu...
Gespeichert in:
Veröffentlicht in: | Virology (New York, N.Y.) N.Y.), 1994-05, Vol.200 (2), p.696-701 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 701 |
---|---|
container_issue | 2 |
container_start_page | 696 |
container_title | Virology (New York, N.Y.) |
container_volume | 200 |
creator | Kleim, Jörg-Peter Bender, Rudolf Kirsch, Reinhard Meichsner, Christoph Paessens, Arno Rieb, Günther |
description | S-2720 and other members of the quinoline/quinoxaline class of HIV-1-specific nonnucleoside reverse transcriptase inhibitors (NNRTIs) select for a glycine to glutamate substitution at residue 190 (Gly 190 Glu) of the reverse transcriptace (RT), when drug-resistant viruses are generated in cell culture. This mutation has not been described to appear upon selection for resistant viral variants using derivatives of any other class of NNRTIs. Notably, the RNA-dependent DNA polymerase activity of the Gly 190 Glu mutant enzyme is drastically diminished with respect to the wild-type RT. We describe here the effects of other amino acid substitutions at position 190 of the RT that were introduced by using site-directed mutagenesis. Polymerase activities and sensitivities to inhibition by a number of NNRTIs were determined for the different RT mutants. In general, an inverse correlation was found between the enzymatic activity and increasing length of the side chain, whereas the size of the residue and the level of resistance to NNRTIs appeared to be positively related. Double mutants, which contain the Gly 190 Glu mutation together with substitutions that confer resistance to other RT inhibitors, were all shown to possess severely diminished polymerase activity. |
doi_str_mv | 10.1006/viro.1994.1233 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16899796</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0042682284712335</els_id><sourcerecordid>16899796</sourcerecordid><originalsourceid>FETCH-LOGICAL-c368t-363b591a13298666e35f9a6726c19c7ee1b28755050cc2d9bfd3d95546a5b72e3</originalsourceid><addsrcrecordid>eNp1kEtLxDAQgIMo67p69Sb0IN665tGkzVFEXUERZPUa0nQKkT7WTLuw_97UXbx5mWGYb4aZj5BLRpeMUnW79aFfMq2zJeNCHJE5o1qlVGTsmMwpzXiqCs5PyRniF411ntMZmeWSCc3ZnJjXcbCD7zvbJHcx7NBj0tfJO6CvRkiYplO5GlvbJc9tO3Z9BbV3Hjq3Sz59GDFZ7zYRjCNbCAjJOtgOXfCbwSKck5PaNggXh7wgH48P6_tV-vL29Hx_95I6oYohFUqUUjPLBNeFUgqErLVVOVeOaZcDsJIXuZRUUud4pcu6EpWWMlNWljkHsSA3-72b0H-PgINpPTpoGttBP6JhqtA61yqCyz3oQo8YoDab4FsbdoZRMxk1k1EzGTWT0Thwddg8li1Uf_hBYexfH_oWnW3q-L3z-IdljHKpJqzYYxAtbD0Eg78SofIB3GCq3v93wQ9oKJEV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16899796</pqid></control><display><type>article</type><title>Mutational Analysis of Residue 190 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Kleim, Jörg-Peter ; Bender, Rudolf ; Kirsch, Reinhard ; Meichsner, Christoph ; Paessens, Arno ; Rieb, Günther</creator><creatorcontrib>Kleim, Jörg-Peter ; Bender, Rudolf ; Kirsch, Reinhard ; Meichsner, Christoph ; Paessens, Arno ; Rieb, Günther</creatorcontrib><description>S-2720 and other members of the quinoline/quinoxaline class of HIV-1-specific nonnucleoside reverse transcriptase inhibitors (NNRTIs) select for a glycine to glutamate substitution at residue 190 (Gly 190 Glu) of the reverse transcriptace (RT), when drug-resistant viruses are generated in cell culture. This mutation has not been described to appear upon selection for resistant viral variants using derivatives of any other class of NNRTIs. Notably, the RNA-dependent DNA polymerase activity of the Gly 190 Glu mutant enzyme is drastically diminished with respect to the wild-type RT. We describe here the effects of other amino acid substitutions at position 190 of the RT that were introduced by using site-directed mutagenesis. Polymerase activities and sensitivities to inhibition by a number of NNRTIs were determined for the different RT mutants. In general, an inverse correlation was found between the enzymatic activity and increasing length of the side chain, whereas the size of the residue and the level of resistance to NNRTIs appeared to be positively related. Double mutants, which contain the Gly 190 Glu mutation together with substitutions that confer resistance to other RT inhibitors, were all shown to possess severely diminished polymerase activity.</description><identifier>ISSN: 0042-6822</identifier><identifier>EISSN: 1096-0341</identifier><identifier>DOI: 10.1006/viro.1994.1233</identifier><identifier>PMID: 7513921</identifier><identifier>CODEN: VIRLAX</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Antiviral Agents - pharmacology ; Base Sequence ; Benzodiazepines - pharmacology ; Benzoxazoles - pharmacology ; Biological and medical sciences ; Delavirdine ; DNA Mutational Analysis ; Drug Resistance, Microbial - genetics ; Fundamental and applied biological sciences. Psychology ; Genetics ; HIV Reverse Transcriptase ; HIV-1 - enzymology ; HIV-1 - genetics ; human immunodeficiency virus 1 ; Imidazoles - pharmacology ; Indoles - pharmacology ; Microbiology ; Molecular Sequence Data ; Mutagenesis, Site-Directed ; Nevirapine ; Piperazines - pharmacology ; Pyridines - pharmacology ; Pyridones - pharmacology ; Quinoxalines - pharmacology ; Reverse Transcriptase Inhibitors ; RNA-Directed DNA Polymerase - drug effects ; RNA-Directed DNA Polymerase - genetics ; Selection, Genetic ; Structure-Activity Relationship ; Virology</subject><ispartof>Virology (New York, N.Y.), 1994-05, Vol.200 (2), p.696-701</ispartof><rights>1994 Academic Press</rights><rights>1994 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c368t-363b591a13298666e35f9a6726c19c7ee1b28755050cc2d9bfd3d95546a5b72e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1006/viro.1994.1233$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4102561$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7513921$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kleim, Jörg-Peter</creatorcontrib><creatorcontrib>Bender, Rudolf</creatorcontrib><creatorcontrib>Kirsch, Reinhard</creatorcontrib><creatorcontrib>Meichsner, Christoph</creatorcontrib><creatorcontrib>Paessens, Arno</creatorcontrib><creatorcontrib>Rieb, Günther</creatorcontrib><title>Mutational Analysis of Residue 190 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase</title><title>Virology (New York, N.Y.)</title><addtitle>Virology</addtitle><description>S-2720 and other members of the quinoline/quinoxaline class of HIV-1-specific nonnucleoside reverse transcriptase inhibitors (NNRTIs) select for a glycine to glutamate substitution at residue 190 (Gly 190 Glu) of the reverse transcriptace (RT), when drug-resistant viruses are generated in cell culture. This mutation has not been described to appear upon selection for resistant viral variants using derivatives of any other class of NNRTIs. Notably, the RNA-dependent DNA polymerase activity of the Gly 190 Glu mutant enzyme is drastically diminished with respect to the wild-type RT. We describe here the effects of other amino acid substitutions at position 190 of the RT that were introduced by using site-directed mutagenesis. Polymerase activities and sensitivities to inhibition by a number of NNRTIs were determined for the different RT mutants. In general, an inverse correlation was found between the enzymatic activity and increasing length of the side chain, whereas the size of the residue and the level of resistance to NNRTIs appeared to be positively related. Double mutants, which contain the Gly 190 Glu mutation together with substitutions that confer resistance to other RT inhibitors, were all shown to possess severely diminished polymerase activity.</description><subject>Antiviral Agents - pharmacology</subject><subject>Base Sequence</subject><subject>Benzodiazepines - pharmacology</subject><subject>Benzoxazoles - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Delavirdine</subject><subject>DNA Mutational Analysis</subject><subject>Drug Resistance, Microbial - genetics</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetics</subject><subject>HIV Reverse Transcriptase</subject><subject>HIV-1 - enzymology</subject><subject>HIV-1 - genetics</subject><subject>human immunodeficiency virus 1</subject><subject>Imidazoles - pharmacology</subject><subject>Indoles - pharmacology</subject><subject>Microbiology</subject><subject>Molecular Sequence Data</subject><subject>Mutagenesis, Site-Directed</subject><subject>Nevirapine</subject><subject>Piperazines - pharmacology</subject><subject>Pyridines - pharmacology</subject><subject>Pyridones - pharmacology</subject><subject>Quinoxalines - pharmacology</subject><subject>Reverse Transcriptase Inhibitors</subject><subject>RNA-Directed DNA Polymerase - drug effects</subject><subject>RNA-Directed DNA Polymerase - genetics</subject><subject>Selection, Genetic</subject><subject>Structure-Activity Relationship</subject><subject>Virology</subject><issn>0042-6822</issn><issn>1096-0341</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtLxDAQgIMo67p69Sb0IN665tGkzVFEXUERZPUa0nQKkT7WTLuw_97UXbx5mWGYb4aZj5BLRpeMUnW79aFfMq2zJeNCHJE5o1qlVGTsmMwpzXiqCs5PyRniF411ntMZmeWSCc3ZnJjXcbCD7zvbJHcx7NBj0tfJO6CvRkiYplO5GlvbJc9tO3Z9BbV3Hjq3Sz59GDFZ7zYRjCNbCAjJOtgOXfCbwSKck5PaNggXh7wgH48P6_tV-vL29Hx_95I6oYohFUqUUjPLBNeFUgqErLVVOVeOaZcDsJIXuZRUUud4pcu6EpWWMlNWljkHsSA3-72b0H-PgINpPTpoGttBP6JhqtA61yqCyz3oQo8YoDab4FsbdoZRMxk1k1EzGTWT0Thwddg8li1Uf_hBYexfH_oWnW3q-L3z-IdljHKpJqzYYxAtbD0Eg78SofIB3GCq3v93wQ9oKJEV</recordid><startdate>19940501</startdate><enddate>19940501</enddate><creator>Kleim, Jörg-Peter</creator><creator>Bender, Rudolf</creator><creator>Kirsch, Reinhard</creator><creator>Meichsner, Christoph</creator><creator>Paessens, Arno</creator><creator>Rieb, Günther</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>19940501</creationdate><title>Mutational Analysis of Residue 190 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase</title><author>Kleim, Jörg-Peter ; Bender, Rudolf ; Kirsch, Reinhard ; Meichsner, Christoph ; Paessens, Arno ; Rieb, Günther</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c368t-363b591a13298666e35f9a6726c19c7ee1b28755050cc2d9bfd3d95546a5b72e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Antiviral Agents - pharmacology</topic><topic>Base Sequence</topic><topic>Benzodiazepines - pharmacology</topic><topic>Benzoxazoles - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Delavirdine</topic><topic>DNA Mutational Analysis</topic><topic>Drug Resistance, Microbial - genetics</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetics</topic><topic>HIV Reverse Transcriptase</topic><topic>HIV-1 - enzymology</topic><topic>HIV-1 - genetics</topic><topic>human immunodeficiency virus 1</topic><topic>Imidazoles - pharmacology</topic><topic>Indoles - pharmacology</topic><topic>Microbiology</topic><topic>Molecular Sequence Data</topic><topic>Mutagenesis, Site-Directed</topic><topic>Nevirapine</topic><topic>Piperazines - pharmacology</topic><topic>Pyridines - pharmacology</topic><topic>Pyridones - pharmacology</topic><topic>Quinoxalines - pharmacology</topic><topic>Reverse Transcriptase Inhibitors</topic><topic>RNA-Directed DNA Polymerase - drug effects</topic><topic>RNA-Directed DNA Polymerase - genetics</topic><topic>Selection, Genetic</topic><topic>Structure-Activity Relationship</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kleim, Jörg-Peter</creatorcontrib><creatorcontrib>Bender, Rudolf</creatorcontrib><creatorcontrib>Kirsch, Reinhard</creatorcontrib><creatorcontrib>Meichsner, Christoph</creatorcontrib><creatorcontrib>Paessens, Arno</creatorcontrib><creatorcontrib>Rieb, Günther</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Virology (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kleim, Jörg-Peter</au><au>Bender, Rudolf</au><au>Kirsch, Reinhard</au><au>Meichsner, Christoph</au><au>Paessens, Arno</au><au>Rieb, Günther</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mutational Analysis of Residue 190 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase</atitle><jtitle>Virology (New York, N.Y.)</jtitle><addtitle>Virology</addtitle><date>1994-05-01</date><risdate>1994</risdate><volume>200</volume><issue>2</issue><spage>696</spage><epage>701</epage><pages>696-701</pages><issn>0042-6822</issn><eissn>1096-0341</eissn><coden>VIRLAX</coden><abstract>S-2720 and other members of the quinoline/quinoxaline class of HIV-1-specific nonnucleoside reverse transcriptase inhibitors (NNRTIs) select for a glycine to glutamate substitution at residue 190 (Gly 190 Glu) of the reverse transcriptace (RT), when drug-resistant viruses are generated in cell culture. This mutation has not been described to appear upon selection for resistant viral variants using derivatives of any other class of NNRTIs. Notably, the RNA-dependent DNA polymerase activity of the Gly 190 Glu mutant enzyme is drastically diminished with respect to the wild-type RT. We describe here the effects of other amino acid substitutions at position 190 of the RT that were introduced by using site-directed mutagenesis. Polymerase activities and sensitivities to inhibition by a number of NNRTIs were determined for the different RT mutants. In general, an inverse correlation was found between the enzymatic activity and increasing length of the side chain, whereas the size of the residue and the level of resistance to NNRTIs appeared to be positively related. Double mutants, which contain the Gly 190 Glu mutation together with substitutions that confer resistance to other RT inhibitors, were all shown to possess severely diminished polymerase activity.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>7513921</pmid><doi>10.1006/viro.1994.1233</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0042-6822 |
ispartof | Virology (New York, N.Y.), 1994-05, Vol.200 (2), p.696-701 |
issn | 0042-6822 1096-0341 |
language | eng |
recordid | cdi_proquest_miscellaneous_16899796 |
source | MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals |
subjects | Antiviral Agents - pharmacology Base Sequence Benzodiazepines - pharmacology Benzoxazoles - pharmacology Biological and medical sciences Delavirdine DNA Mutational Analysis Drug Resistance, Microbial - genetics Fundamental and applied biological sciences. Psychology Genetics HIV Reverse Transcriptase HIV-1 - enzymology HIV-1 - genetics human immunodeficiency virus 1 Imidazoles - pharmacology Indoles - pharmacology Microbiology Molecular Sequence Data Mutagenesis, Site-Directed Nevirapine Piperazines - pharmacology Pyridines - pharmacology Pyridones - pharmacology Quinoxalines - pharmacology Reverse Transcriptase Inhibitors RNA-Directed DNA Polymerase - drug effects RNA-Directed DNA Polymerase - genetics Selection, Genetic Structure-Activity Relationship Virology |
title | Mutational Analysis of Residue 190 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A58%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mutational%20Analysis%20of%20Residue%20190%20of%20Human%20Immunodeficiency%20Virus%20Type%201%20Reverse%20Transcriptase&rft.jtitle=Virology%20(New%20York,%20N.Y.)&rft.au=Kleim,%20J%C3%B6rg-Peter&rft.date=1994-05-01&rft.volume=200&rft.issue=2&rft.spage=696&rft.epage=701&rft.pages=696-701&rft.issn=0042-6822&rft.eissn=1096-0341&rft.coden=VIRLAX&rft_id=info:doi/10.1006/viro.1994.1233&rft_dat=%3Cproquest_cross%3E16899796%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16899796&rft_id=info:pmid/7513921&rft_els_id=S0042682284712335&rfr_iscdi=true |